Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 6;19(1):779.
doi: 10.1186/s12879-019-4375-7.

Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana

Blackson Pitolo Tembo  1 , Ntambwe Gustav Malangu  2
Affiliations

Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana

Blackson Pitolo Tembo et al. BMC Infect Dis. .

Abstract

Background: To investigate the prevalence and factors associated with the prevalence of multidrug/rifampicin-resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.

Methods: A retrospective review of medical records of suspected drug resistant tuberculosis patients receiving care at public health facilities in Botswana was conducted from January, 2013 and December, 2014. Patient characteristics and drug susceptibility data were abstracted from 2568 medical records on to a pre-tested checklist form. The prevalence of multidrug/rifampicin resistance was computed. Bivariate and multivariate logistic regression was carried out to determine the factors associated with the prevalence of multidrug/rifampicin in the study population.

Results: Overall, multidrug/ rifampicin - resistance among suspected drug resistant tuberculosis patients in Botswana were found in 139 (5.4%) cases with 1.3% among new cases and 7.7% among previously treated tuberculosis patients. Being a previously treated tuberculosis patient and having a positive smear were found to be factors associated with the prevalence of multidrug/rifampicin-resistant tuberculosis (p < 0.05). However, age, sex, living in urban area and HIV status were not associated with this disease (p > 0.05).

Conclusion: This study highlights a low burden of multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients receiving care at public health facilities in Botswana. Strategies in controlling MDR/RR-TB should emphasize on effective implementation of Directly Observation Treatment - short course strategy, continuous surveillance of drug resistance cases, prevention of the development of new cases of MDR/RR-TB and to treat existing patients. Further interventions should focus on strengthening TB infection control activities.

Keywords: Associated factors; Botswana; MDR/RR-TB; Prevalence; Retrospective review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests (financial or non-financial).

Figures

Fig. 1
Fig. 1
Enrollment of the study population
Fig. 2
Fig. 2
Proportion of MDR/RR-TB among new and previously treated TB cases
Fig. 3
Fig. 3
Distribution of multidrug-resistant tuberculosis cases among suspected DR-TB patients stratified by age group and sex
Fig. 4
Fig. 4
Methods used to detect drug resistance
See this image and copyright information in PMC

References

    1. World Health Organization. Global Tuberculosis Report 2016. World Health Organization, 2016. WHO/HTM/TB/2016.13.
    1. Desissa F, Workineh T, Beyene T. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug – resistant tuberculosis treatment in east Shoa, Ethiopia. BMC Public Health. 2018;18:422. doi: 10.1186/s12889-018-5371-3. - DOI - PMC - PubMed
    1. Daniel Olusoji, Osman Eltayeb. Prevalence and risk factors associated with drug resistant TB in South West, Nigeria. Asian Pacific Journal of Tropical Medicine. 2011;4(2):148–151. doi: 10.1016/S1995-7645(11)60057-6. - DOI - PubMed
    1. Girum T, Tariku Y, Dessu S. Survival status and treatment outcome of multidrug resistant tuberculosis (MDR-TB) among patients treated in treatment initiation centers (TIC) in South Ethiopia: a retrospective cohort study. Ann Med Health Sci res. 2017;7:331–336.
    1. Barman N, Ghosh D, Rahman Q, Uddin MN, Ahmed S, Paul D. Assessment of risk factors of multidrug resistant tuberculosis with emphasis on serum zinc. Bangladesh Med J. 2014;43:1. doi: 10.3329/bmj.v43i1.21368. - DOI

MeSH terms

LinkOut - more resources